On September 5, 2022, Prestige Biologics Co., Ltd closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8,000 KRW | -0.12% | -0.37% | -15.61% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.61% | 69.86M | |
-4.35% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- A950210 Stock
- News Prestige BioPharma Limited
- Prestige Biologics Co., Ltd. announced that it has received KRW 6.893915 billion in funding from Prestige BioPharma Limited